Evidence map›Paper›PMID 35617261›Full record

ArticlePloS one2022

Substance use disorder among adolescents before and during the COVID-19 pandemic in Uganda: Retrospective findings from a psychiatric ward registry.

Mark Mohan Kaggwa, Joan Abaatyo, Emmanuel Alol, Moses Muwanguzi, Sarah Maria Najjuka, Alain Favina, Godfrey Zari Rukundo, Scholastic Ashaba, Mohammed A Mamun

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mark Mohan KaggwaDepartment of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID 0000-0002-4733-154X
Joan AbaatyoDepartment of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Emmanuel AlolDepartment of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Moses MuwanguziFaculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Sarah Maria NajjukaCollege of Health Sciences, Makerere University, Kampala, Uganda.
Alain FavinaDepartment of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Godfrey Zari RukundoDepartment of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Scholastic AshabaDepartment of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Mohammed A MamunCHINTA Research Bangladesh, Savar, Dhaka, Bangladesh.ORCID 0000-0002-1728-8966
Mbarara University of Science and Technology · UGDaffodil International University · BDMakerere University · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been reported that the COVID-19 pandemic has predisposed adolescents to risky behaviors such as substance use and subsequent substance use disorder (SUD). However, it is unknown how the pandemic has changed the prevalence of SUD among adolescents in Uganda. We aimed to determine the prevalence of SUD and associated factors among adolescents in southwestern Uganda. Retrospectively, psychiatry ward records from November 2018 to July 2021 were collected from the largest tertiary hospital in southwestern Uganda. A total of 441 adolescent records were included in the analysis, with a mean age was 17±1.88 years, and the majority were males (50.34%). The overall prevalence of SUD was 7.26% (5.90% and 9.80% before and during the pandemic). Despite a little rise in SUD (3.9% increment) during the COVID-19 pandemic, there was no statistical difference compared to before the pandemic. The likelihood of being diagnosed with SUD was more among older adolescents at any period. In addition, having a diagnosis of bipolar mood disorder reduced the likelihood of SUD during the pandemic. This study indicated no statistical change in the diagnosis of SUD among adolescents before and during the COVID-19 pandemic. As older-male adolescents (17 to 19 years) were at higher risk of SUD, there is a need for early intervention for this group.

Indexed as

COVID-19Substance-Related DisordersAdolescentComorbidityFemaleHumansMalePandemicsPsychiatric Department, HospitalRegistriesRetrospective StudiesUganda

Identifiers

PMID35617261
PMCPMC9135190
OpenAlexW4281559894

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.